Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial
出版年份 2023 全文链接
标题
Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial
作者
关键词
-
出版物
JOURNAL OF INFECTION
Volume 87, Issue 1, Pages 18-26
出版商
Elsevier BV
发表日期
2023-04-20
DOI
10.1016/j.jinf.2023.04.012
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters
- (2023) Ai-ris Y. Collier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Response to Omicron BA.4–BA.5 Bivalent Booster
- (2023) Qian Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
- (2022) Hung Fu Tseng et al. NATURE MEDICINE
- Homologous and Heterologous Covid-19 Booster Vaccinations
- (2022) Robert L. Atmar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
- (2022) Jill M. Ferdinands et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.
- (2022) Xinxue Liu et al. JOURNAL OF INFECTION
- Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial
- (2022) Alasdair P S Munro et al. LANCET INFECTIOUS DISEASES
- Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
- (2022) Nick Andrews et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protection by a Fourth Dose of BNT162b2 against Omicron in Israel
- (2022) Yinon M. Bar-On et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
- (2022) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Six-month follow-up of a booster dose of CoronaVac in two single-centre phase 2 clinical trials
- (2022) Qianqian Xin et al. Nature Communications
- Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study
- (2022) Ramandip Grewal et al. BMJ-British Medical Journal
- Durability of Heterologous and Homologous COVID-19 Vaccine Boosts
- (2022) C. Sabrina Tan et al. JAMA Network Open
- Antibody response 6 months after the booster dose of Pfizer in previous recipients of CoronaVac
- (2022) Maria Francilene Souza Silva et al. JOURNAL OF MEDICAL VIROLOGY
- Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
- (2021) Alasdair P S Munro et al. LANCET
- Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance
- (2021) Sue Pavord et al. BMJ-British Medical Journal
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search